Background: Immunosuppression and age-related deficiencies in cell-mediated immunity are important factors for the reactivation of latent varicella-zoster virus (VZV). 
INTRODUCTION
Varicella results from primary infection with varicella-zoster virus (VZV), and herpes zoster is caused by the reactivation of latent VZV in the sensory ganglia 1 . The mechanisms underlying the reactivation of latent VZV are unclear. However, reactivation is related to immunodeficiency, irradiation of the spinal column, and local trauma, and the most important factor for reactivation is decreased VZV-specific cell-mediated immunity with advancing age 1 . A recent study confirmed that VZV-specific T cells in the peripheral blood decrease with advancing age, whereas regulatory T (Treg) cells increase 2 . T cell-mediated immunity may play an important role in the reactivation of VZV via changes in CD4 + T cells and cytotoxic CD8 + T cells after the development of herpes zoster 3, 4 .
Tissue injury in common viral infections can be directly caused by viral replication or immunopathology; it also occurs as a result of an increased inflammatory response associated with viral replication or the inhibition of the inflammatory response to the virus 5 Although recent studies have examined changes in Treg cells in the peripheral blood and postherpetic neuralgia (PHN) in patients with herpes zoster, no study has evaluated the correlation between Treg cells and Th17 cells.
In the present study, Treg cells, Th17 cells, and the Th17/Treg cell ratio were examined in the peripheral blood from patients with herpes zoster and normal controls using flow cytometry to investigate their correlations with the pathogenesis of herpes zoster.
MATERIALS AND METHODS

Subjects
The subjects consisted of 25 patients with herpes zoster, including 13 inpatients who visited the Dermatology Department outpatient care clinic at this hospital and were diagnosed with herpes zoster from September 2015 to March 2016 and 21 healthy controls recruited during the same period. The present study was approved by the Institutional Review Board of Chosun University Hospital, Gwangju, Korea (IRB no. CHOSUN 2015-07-013-001).
All subjects agreed to participate in the study. Patients were excluded if they were taking any antiviral drug prescribed at another hospital prior to their visit to this hospital, if they took any anti-inflammatory analgesic drug for the purpose of pain control prior to treatment, and if they were lost to follow-up. Controls with similar age and gender distributions were recruited among general individuals who did not have herpes zoster, received no vaccination against herpes zoster within one year, and had no past history or family history of autoimmune diseases, as identified in an interview.
Methods
Blood was collected once from all subjects before treatment, and blood was collected one additional time from the hospitalized patients after treatment for 5 days or before discharge from the hospital to measure changes in Treg and Th17 cells before and after treatment. The hospitalized patients received treatment with acyclovir at a dose of 5 mg/kg intravenously three times daily for 5 days with analgesics and didn't take any systemic agents including systemic glucocorticosteroid that may affect immune cells. The affected body surface area (BSA) was measured using clinical photographs obtained at admission. Pain scores before and after treatment were assessed on a scale from 0 (no pain) to 10 points (the most severe pain) in patients with herpes zoster using the visual analog scale (VAS). PHN was defined as a pain index of greater than 30% of the initial pain even after 4 weeks of skin rash 8 , and the development of PHN was examined after 4 weeks of hospital treatment. The proportions of Treg cells and Th17 cells and the Th17/Treg ratio were compared in patients with herpes zoster before and after treatment to evaluate the effects of treatment. The relationships between the proportion of each of T cell subset in the peripheral blood and herpes zoster-related clinical parameters, such as disease duration, pain scores, presence or absence of PHN, and affected area of skin (BSA), were evaluated.
Cell isolation
Venous blood (10 ml per subject) was collected from patients with herpes zoster and normal controls in heparin-treated tubes. Ficoll-Paque TM PLUS (10 ml) (GE Healthcare Bio-Sciences AB, Uppsala, Sweden) was added to a 50-ml tube and the blood was then carefully added to the top of Ficoll-Paque TM PLUS, followed by centrifugation for 40 min (400×g, 20 o C). After centrifugation, 3 ml of the peripheral blood mononuclear cell (PBMC) fraction was pipetted using a micropipette, and was transferred to a 15-ml tube, mixed thoroughly with phosphate-buffered saline, and washed twice (200×g, 10 minutes, 20 o C) to prepare PBMCs.
Flow cytometric analysis
Th17 cells were defined as helper T cells that produce interleukin (IL)-17. The IL-17 Secretion Assay-Detection Kit (Miltenyi Biotec, Bergisch Gladbach, Germany) was used to determine the number of cells that produce IL-17. Two samples of 5×10 6 PBMCs cultured in 500 μl of RPMI 1640 with 5% human serum were prepared according to the manufacturer's protocol, and each sample was added to a 48-well plate. T cells were stimulated with CytoStim Ⓡ (Miltenyi Biotec) (10 μl) in one 48-well plate, and were cultured in a 5% CO2 incubator at 37 o C for 4 hours. CytoStim Ⓡ induces the activation of T cells. Activated CD4 + T cells may secrete effector cytokines within several hours or begin to express activation markers on cell surfaces. After cultivation, each sample was stained with monoclonal antibodies against CD4-fluorescein isothiocyanate (FITC) and IL-17-allophycocyanin (APC). The sample without CytoStim Ⓡ was treated as the negative con- Fig. 1A ). In contrast, the number of Th17 cells was higher in the group of patients with herpes zoster (0.63±0.36%) than in the control group (0.38± 0.19%), and this difference was statistically significant (p=0.012, Fig. 1B ). In order to investigate the imbalance between the two T cell subsets, the ratios of Th17 cells to Treg cells were calculated. These Th17/Treg cell ratios were statistically significantly higher in the group of patients with herpes zoster (0.92±1.07) than in the control group (0.38±0.36) (p=0.013, Fig. 1C ).
Comparison of Treg and Th17 cells before and after treatment in patients with herpes zoster
Mean time duration from pre-treatment to post-treatment sample of blood was about 5.2 days. In a quantitative comparison of Treg cells and TH17 cells in the peripheral blood from 15 hospitalized patients with herpes zoster between before and after treatment, there were fewer Treg cells after treatment (0.73±0.59%) than before treatment (1.09±0.83%), but this difference was not statistically significant (p=0.455, Fig. 2A ). There were fewer Th17 cells after treatment (0.45±0.29%) than before treatment (0.61±0.33%), but a statistically significant difference was not observed (p=0.173, Fig. 2B ). To investigate the imbalance between Treg cells and Th17 cells, the ratios of Th17 cells to Treg cells were calculated and there was no statistically significant difference between this ratio before treatment (1.16±1.41) and after treatment (0.97±0.84) (p=0.735, Fig. 2C ).
Correlations between clinical parameters and the numbers of Treg and Th17 cells in patients with herpes zoster
The mean VAS before treatment in the hospitalized patients with herpes zoster was 5.8, and the mean VAS after treatment was 2.53, indicating that pain score improved after treatment. There were no significant correlations between the change of the pain score and those of Treg cells, Th17 cells, or Th17/Treg ratio before and after treatment (Fig. 3A∼C) . Additionally, no significant difference was observed between Treg cells, Th17 cells, or the Th17/Treg ratio before treatment with respect to the presence or absence of PHN (Fig. 3D∼F) . However, there was a statistically significant negative correlation between BSA and Treg cells in the patients and a statistically significant positive correlation between BSA and Th17 cells and, the Th17/Treg ratio ( Table 2 , Fig. 3G∼I ).
DISCUSSION
Herpes zoster caused by the reactivation of VZV is characterized by grouped vesicles accompanied by severe pain, and PHN, i.e., pain persisting for several months or years after the rash has resolved, can develop as a consequence 9, 10 . The cellular mechanisms of the reactivation of the latent virus and the precise causes of PHN are unclear 3 . However, in view of the fact that treatments or diseases that affect the functions of T cells increase the risk of herpes zoster and HIV-infected patients with a progressive decrease in CD4 + cells are at high risk for herpes zoster, cell-mediated T cells are thought to play an important role in the development of herpes zoster 3, 9 . Treg differentiation and Th17 differentiation are related processes; the two T cell subsets play an important role in maintaining immunological homeostasis and there may exist an important plasticity of the two T cell subsets 7 .
A recent study has reported that during viral infection, CD4 + CD25 + Treg cells inhibit the activation and functions of effector T cells and, in turn, control antiviral responses 3 . Tissue damage in viral infection can be caused directly by viral propagation in the tissue, and this is regulated by the antiviral immune response, which acts to suppress viral replication 5 .
Although Treg cells can be beneficial in viral infections by acting to suppress tissue damage caused by virus-specific T cells, Treg cells can suppress host immunity, which is instrumental in eradicating viruses, leading to persistent viral infection and disease progression 12, 13 . CD4 press antigen-specific responses 14 .
Th17 cells that produce IL-17 are associated with inflammatory tissue damage, lead to a variety of autoimmune diseases, and play a key role in host defense against bacterial infections or fungal infections 15 18, 19 . When analyzing the imbalance between the two T cell subsets or each T cell subset and the development of herpes zoster, the ratio of Th17 cells to Treg cells was significantly elevated in patients with herpes zoster compared with normal controls.
The results of the present study confirm that the balance between Treg cells and Th17 cells is critical for the development of herpes zoster, similar to observations that an imbalance between Treg cells and Th17 cells, rather than each T cell subset alone, in chronic viral diseases, such as chronic HBV and HCV infections, affects progression and treatment 6, 7 . The analysis of herpes zoster-affected BSA, Treg cells, Th17 cells, and Th17/Treg ratios showed that significant positive correlations between BSA and Th17 cells and the Th17/Treg ratio and a significant negative correlation between BSA and Treg cells. Accordingly, the affected area may reflect cellular changes in the peripheral blood. So, we thought that Th17 cells may be associated with herpes zoster per se but also with the extent of lesions. This study had several limitations. The number of participants was relatively small, and the onset time of herpes zoster differed among patients at the time of blood collection; this may explain differences in cellular changes. Treg cells generally tend to increase with age. Although the mean age of controls was higher than that of patients with herpes zoster, age-related changes were not considered in this study. In addition, when the proportions of Treg cells and Th17 cells in the peripheral blood were compared before and after treatment, blood was collected during a short period of time, i.e., 1 week, to observe changes in each cell type, based on the fact that that viral replication is generally regulated within 1∼2 weeks 9 .
In the present study, the imbalance between Treg and Th17 cells and the development of herpes zoster was examined to determine the effects of Treg and Th17 cells on the reactivation of VZV and to examine the imbalance in Treg and TH17 cells and the development of herpes zoster.
In conclusion, the number of Th17 cells and the ratio of Th17 to Treg cells were significantly higher in patients with herpes zoster than in healthy controls. And, there was a significant correlation between the proportion and ratio of Treg and Th17 cells and the affected BSA. Therefore, Th17 was involved in herpes zoster and an imbalance between Treg cells and Th17 cells was observed in patients with herpes zoster. But, additional studies are needed to examine the mechanism by which Treg and Th17 cells influence the development of herpes zoster.
